What the For-Profit Q1 Disclosures Tell Us About 2026 — and Why NFPs Risk Falling Behind

The four largest publicly traded hospital companies — HCA, Tenet, UHS, and Community Health Systems — reported Q1 earnings in late April. Across 327 acute care facilities and roughly $126.7 billion in combined 2025 revenue, the headline was soft acute care volume, but the deeper story was massive outpatient capital deployment moving faster than most not-for-profits (NFP) systems can match.

Four observations from the Q1 calls are worth flagging for industry partners:

1. Q1 softness was a confluence of one-offs and the predicted Exchange decline.

Q1 softness reflected a shorter-than-normal flu season (respiratory-related admissions down 42% at HCA, 40% at Tenet), severe winter storms, and the predicted ACA exchange decline. Exchange patient volumes fell 15% at HCA, 10% at Tenet, 5% at UHS, and 3.9% at CHS. HCA's broad forecast of a $600M–$900M adjusted EBITDA impact from exchange losses suggests the total financial hit remains highly uncertain. All four operators expect the situation to worsen through the year.

2. High-acuity outpatient migration is now the dominant capital story.

Tenet's USPI outpatient surgery subsidiary delivered a 36.7% adjusted EBITDA margin driven by double-digit same-store growth in total joint replacements across its 533 ASCs. Tenet has further deployed $125M (half its annual M&A target) to acquire seven other ASCs and opened three de novos in Q1 alone.

CHS is purchasing a majority stake in an ASC operator in Anchorage and opening two de novo ASCs in Alabama, plus acquiring the Surgical Institute of Alabama — an 8,000+ annual case facility and its largest acquisition since 2016.

HCA cited continued outpatient acquisitions in urgent care, ASC, and freestanding ED platforms.

The takeaway? High-acuity surgical work is migrating outpatient at scale, and multispecialty ASCs in growth markets are the highest-margin growth vehicle available.

3. AI is everywhere, but savings are disclosed nowhere

UHS has eight enterprise AI use cases in revenue cycle alone, Tenet described doubling the productivity of its Conifer analytics team through AI-driven back-office automation,HCA named ambient documentation, patient safety, and nurse engagement initiatives, and CHS is deploying ambient listening to reduce administrative burden on physicians.

But no operator quantified savings or EBITDA contribution from AI deployment. UHS described "significant benefit on a go-forward basis." Tenet referenced productivity gains. HCA framed AI as embedded within its broader $400M savings program. But none disclosed dollar impact, headcount avoidance, or gains in specific revenue cycle metrics.

The investment commitments are real and accelerating, but NFP systems struggling with their own AI deployments may find some comfort in the for-profits not yet having much to show in hard numbers.

4. Capital deployment continues despite the policy backdrop.

Finally, the policy posture contrast is striking. Many NFP boards have made OBBBA a dominant frame for 2026 strategy. The for-profits acknowledged the risk in their 10-Q filings, but their earnings calls were near-silent on OBBBA. What investors heard instead was capital deployment: HCA's $5.5B–$6B project pipeline, Tenet's ASC acquisitions, UHS's behavioral expansion, and CHS’s ambulatory investments. UHS was unique among the four in actually quantifying the impact, estimating $432M—$480M in annual Medicaid revenue reductions by 2032.

So What?

• For NFP systems planning service-line reconfiguration around the same surgical migration, the question isn't whether the trend is real — it's whether their capital position supports moving at the speed the market is setting.

• The AI returns gap — investments everywhere, quantified returns nowhere — suggests the industry is still in the build phase. Partners should prepare for a shift in buyer expectations toward hard ROI evidence.